FindTrial
Sign In

Door-to-Door screening of a type of blood cancer (myeloma) in an Indian village setting

Door-to-Door screening of pecancerous condition for monoclonal gammopathy in Indian Rural setting - M-Com

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/051220
Enrollment
750
Registered
2023-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Armed Forces Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Residents of Kasurdi Village defined as residing in this geographical location of Kasurdi village for more than 1 Year (b) Age more than 50 years (c) Willing to participate

Exclusion criteria

Exclusion criteria: (a) Previously diagnosed cases of any plasma cell dyscrasias or other hematological malignancy (b) Unwilling for informed consent

Design outcomes

Primary

MeasureTime frame
Prevalence of monoclonal gammopathy in otherwise healthy individuals of a rural community in MaharashtraTimepoint: Baseline—

Secondary

MeasureTime frame
To evaluate the correlation of monoclonal gammopathy with (a) Age (b) Gender (c) Albumin-globulin ratioTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Uday Yanamandra

Armed Forces Medical College, Pune

udayj2@gmail.com8195035551

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026